Therapeutic plasma exchange in patients with neurologic diseases: Retrospective multicenter study

Transfusion and Apheresis Science

Volumn 38, Issue 2, 2008, Pages 109-115

  Kaynar, Leylagul ^a   Altuntas, Fevzi ^a   Aydogdu, Ismet ^b   Turgut, Burhan ^c   Kocyigit, Ismail ^a   Hacioglu, Sibel Kabukcu ^d   Ismailogullari, Sevda ^a   Turgut, Nilda ^c   Ali Erkurt, M ^b   Sari, Ismail ^d   Oztekin, Mehmet ^a   Solmaz, Musa ^a   Eser, Bulent ^a   Ozdemir Ersoy, Ali ^a   Unal, Ali ^a   Cetin, Mustafa ^a  

^a Erciyes Medical School   (Turkey)

^b Inonu School of Medicine   (Turkey)

^c TRAKYA UNIVERSITY FACULTY OF MEDICINE   (Turkey)

^d Pamukkale School of Medicine   (Turkey)

Author keywords

Acute disseminated encephalomyelitis (ADEM); Chronic inflammatory demyelinating polyneuropathy (CIDP); Guillain Barr Syndrome (GBS); Multiple sclerosis (MS); Myasthenia gravis (MG); Therapeutic plasma exchange

Indexed keywords

AZATHIOPRINE; IMMUNOGLOBULIN; PREDNISOLONE; PYRIDOSTIGMINE; STEROID;

ADULT; AGED; ANALYTIC METHOD; ARTICLE; CHRONIC INFLAMMATORY DEMYELINATING POLYNEUROPATHY; CLINICAL EVALUATION; CONTROLLED STUDY; ENCEPHALOMYELITIS; FEMALE; GUILLAIN BARRE SYNDROME; HUMAN; HYPOCALCEMIA; HYPOTENSION; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD; MULTIPLE SCLEROSIS; MYASTHENIA GRAVIS; NEUROLOGIC DISEASE; PLASMAPHERESIS; RETROSPECTIVE STUDY; SCORING SYSTEM; STATISTICAL SIGNIFICANCE; UNIVERSITY HOSPITAL;

ADOLESCENT; ADULT; AGED; ENCEPHALOMYELITIS, ACUTE DISSEMINATED; FEMALE; GUILLAIN-BARRE SYNDROME; HUMANS; MALE; MIDDLE AGED; MULTIPLE SCLEROSIS; MYASTHENIA GRAVIS; PLASMA EXCHANGE; PLASMAPHERESIS; POLYRADICULONEUROPATHY, CHRONIC INFLAMMATORY DEMYELINATING; RETROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 42649095636     PISSN: 14730502     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.transci.2007.11.002     Document Type: Article

References (36)

1. Lehmann H.C., Hartung H.P., Hetzel G.R., Stuve O., and Kieseier B.C. Plasma exchange in neuroimmunological disorders. Part 1. Rationale and treatment of inflammatory central nervous system disorders. Arch Neurol 63 (2006) 930-935
2. Lehmann H.C., Hartung H.P., Hetzel G.R., Stuve O., and Kieseier B.C. Plasma exchange in neuroimmunological disorders. Part 2. Treatment of neuromuscular disorders. Arch Neurol 63 (2006) 1066-1071
3. Szczepiorkowski Z.M., Bandarenko N., Kim H.C., Linenberger M.L., Marques M.B., Sarode R., et al. Guidelines on the use of therapeutic apheresis in clinical practice-evidence-based approach from the apheresis applications committee of the american society for apheresis. J Clin Apher. 22 (2007) 106-175
4. Weinstein R. Therapeutic apheresis in neurological disorders. J Clin Apher 15 (2000) 74-128
5. McLeod B.C. Therapeutic plasma exchange in neurologic disorders. In: McLeod B.C., Price T.H., and Weinstein R. (Eds). Apheresis: principles and practice. 2nd ed. (2003), AABB Press, Bethasda, MD 321-344
6. Thanvi B.R., and Lo T.C.N. Update on myasthenia gravis. Postgrad Med J 80 (2004) 690-700
7. Winer J.B. Treatment of Guillain-Barré syndrome. Q J Med 95 (2002) 717-721
8. Said G. Chronic inflammatory demyelinating polyneuropathy. Neuromuscul Disord 16 (2006) 293-303
9. Basic-Jukic N., Kes P., Glavasa-Boras S., Brunetta B., Bubic-Filipi L., and Puretic Z. Complications of therapeutic plasma exchange: experience with 4857 treatments. Ther Apher Dial 9 (2005) 391-395
10. Mokrzycki M.H., and Kaplan A.A. Therapeutic plasma exchange: complications and management. Am J Kidney Dis 23 (1994) 817-827
11. Hughes R.A.C., Newsom-Dawis J.M., Perkin G.D., and Pierce J.M. Controlled trial of prednisolone in acute polyneuropathy. Lancet 2 (1978) 750-753
12. Kuwabara S. Guillain-Barré syndrome: epidemiology, pathophysiology and management. Drugs 6 (2004) 597-610
13. Asbury A.K., and Cornblath D.R. Assessment of current diagnostic criteria for Guillain-Barré syndrome. Ann Neurol 27 (1990) 21-24
14. Shahar E. Current therapeutic options in severe Guillain-Barre syndrome. Clin Neuropharmacol 29 (2006) 45-51
15. The Guillain-Barre Syndrome Study Group. Plasmapheresis and acute Guillain-Barre syndrome. Neurology. 1985;35:1096-104.
16. Van der Meche F.G., and Schmitz P.I. Dutch Guillain-Barre study group. A randomized trial comparing intravenous immune globulin and plasma exchange in Guillain-Barre syndrome. N Engl J Med 326 (1992) 1123-1129
17. The French Cooperative Group on Plasma Exchange in Guillain-Barre Syndrome. Appropriate number of plasma exchanges in Guillain-Barre syndrome. Ann Neurol 1997;4:298-306.
18. Randomised Trial of Plasma Exchange, Intravenous Immunoglobulin, and Combined Treatments in Guillain-Barré Syndrome. Plasma exchange/sandoglobulin Guillain-Barré syndrome trial group. Lancet 1997;49:225-30.
19. Raphael J.C., Chevret S., Hughes R.A.C., and Annane D. Plasma exchange for Guillain-Barre syndrome. Cochrane Database Syst Rev 2 (2002) CD001798
20. Tzartos S.J., Barkas T., Cung M.T., Mamalaki A., Marraud M., Orlewski P., et al. Anatomy of the antigenic structure of a large membrane autoantigen, the muscle-type nicotinic acetylcholine receptor. Immunol Rev 163 (1998) 89-120
21. Levin K.H., and Richman D.P. Myasthenia Gravis. Clin Aspects Autoimmun 4 (1989) 23-31
22. Gajdos P., Chevret S., Clair B., Tranchant C., and Chastang C. Myasthenia gravis clinical study group. Clinical trial of plasma exchange and high-dose intravenous immunoglobulin in myasthenia gravis. Ann Neurol 41 (1997) 789-796
23. Pinching A.F. Remission of myasthenia gravis following plasma exchange. Lancet 2 (1976) 1373-1376
24. Dau P.C., Lindstrom J.M., Cassel C.K., Denys E.H., Shev E.E., and Spitler L.E. Plasmapheresis and immunosuppressive drug therapy in myasthenia gravis. N Engl J Med 297 (1977) 1134-1140
25. Antozzi C., Gemma M., Regi B., Berta E., Confalonieri P., Peluchetti D., et al. A short plasma exchange protocol is effective in severe myasthenia gravis. J Neurol 238 (1991) 103-107
26. Gajdos P. Plasma exchange for myasthenia gravis. Cochrane Database Systemat Rev 4 (2002) CD002275
27. Victor M., and Ropper A.H. Diseases of the peripheral nerves. Principles of neurology. 7th ed. (2001), McGraw-Hill, New York 1380-1387
28. Kanter D.S., Horensky D., Sperling R.A., Kaplan J.D., Malachowski M.E., and Churchill W.H. Plasmapheresis in fulminant acute disseminated encephalomyelitis. Neurology 45 (1995) 824-827
29. Shah A.K., Tselis A., and Mason B. Acute disseminated encephalomyelitis in a pregnant woman successfully treated with plasmapheresis. J Neurol Sci 174 (2000) 147-151
30. Keegan M., Pineda A.A., McClelland R.L., Darby C.H., Rodriguez M., and Weinshenker B.G. Plasma exchange for severe attacks of CNS demyelination: predictors of response. Neurology 58 (2002) 143-146
31. Weinshenker B., and Lucchinetti C. Acute leukoencephalopathies: differential diagnosis and investigation. Neurologist 4 (1998) 148-166
32. Dyck P.J., Lais A.C., Ohta M., Bastron J.A., Okazaki H., and Groover R.V. Chronic inflammatory demyelinating polyradiculopathy. N Engl J Med 314 (1986) 461-465
33. Altuntas F., Aydogdu I., Kabukcu S., Kocyigit I., Cikim K., Sari I., et al. Therapeutic plasma exchange for the treatment of thrombotic thrombocytopenic purpura: a retrospective multicenter study. Transfus Apher Sci 36 1 (2007) 57-67
34. Eser B., Guven M., Unal A., Coskun R., Altuntas F., Sungur M., et al. The role of plasma exchange in HELLP syndrome. Clin Appl Thromb Hemost 11 2 (2005) 211-217
35. Lazo-Langner A., Espinosa-Poblano I., Tirado-Cardenas N., Ramirez-Arvizu P., Lopez-Salmoran J., Penaloza-Ramirez P., et al. Therapeutic plasma exchange in Mexico: experience from a single institution. Am J Hematol 70 (2002) 16-21
36. Yeo F.E., Bohen E.M., Yuan C.M., Sawyers E.S., and Abbott K.C. Therapeutic plasma exchange as a nephrological procedure: a single-center experience. J Clin Apher 20 (2005) 208-216